Karianne Svendsen, Jacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, David R. Jacobs, Martin P. Bogsrud, Kirsten B. Holven, Kjetil Retterstøl
{"title":"家族性高胆固醇血症孕妇不良妊娠结局的风险和使用他汀类药物的影响","authors":"Karianne Svendsen, Jacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, David R. Jacobs, Martin P. Bogsrud, Kirsten B. Holven, Kjetil Retterstøl","doi":"10.1101/2024.09.03.24312275","DOIUrl":null,"url":null,"abstract":"<strong>Background and aims</strong> Sparse data exist on the possible risk of adverse pregnancy outcomes in women with familial hypercholesterolemia (FH). We investigated associations between having a FH diagnosis and adverse pregnancy outcomes, and between statin exposure in pregnancy and adverse pregnancy outcomes among women with FH.","PeriodicalId":501071,"journal":{"name":"medRxiv - Epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia\",\"authors\":\"Karianne Svendsen, Jacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, David R. Jacobs, Martin P. Bogsrud, Kirsten B. Holven, Kjetil Retterstøl\",\"doi\":\"10.1101/2024.09.03.24312275\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Background and aims</strong> Sparse data exist on the possible risk of adverse pregnancy outcomes in women with familial hypercholesterolemia (FH). We investigated associations between having a FH diagnosis and adverse pregnancy outcomes, and between statin exposure in pregnancy and adverse pregnancy outcomes among women with FH.\",\"PeriodicalId\":501071,\"journal\":{\"name\":\"medRxiv - Epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.09.03.24312275\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.03.24312275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia
Background and aims Sparse data exist on the possible risk of adverse pregnancy outcomes in women with familial hypercholesterolemia (FH). We investigated associations between having a FH diagnosis and adverse pregnancy outcomes, and between statin exposure in pregnancy and adverse pregnancy outcomes among women with FH.